
    
      They are categorized into three groups: (1) patients who have positive result of culture with
      equal to or more than three susceptible antibiotics are treated by non-bismuth quadruple
      therapy (rabeprazole 20 mg q.d.s. and three effective antibiotics), (2) patients who have
      positive result of culture with one or two susceptible antibiotics are treated by
      bismuth-containing therapy (rabeprazole 20 mg q.d.s., bismuth subcitrate 120 mg q.d.s. and
      all the effective antibiotics), and (3) patients who have negative result of culture or whose
      culture data are unavailable will be treated by (rabeprazole 20 mg q.d.s, amoxicillin 500 mg
      q.d.s., tetracycline 500 mg q.d.s. and levofloxacin 500 mg o.d.) for 14 days.
    
  